133 related articles for article (PubMed ID: 15592577)
21. Patency trials with reteplase (r-PA): what do they tell us?
Bode C; Nordt TK; Peter K; Smalling RW; Runge MS; Kübler W
Am J Cardiol; 1996 Dec; 78(12A):16-9. PubMed ID: 8990406
[TBL] [Abstract][Full Text] [Related]
22. Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis.
D'Souza SP; Mamas MA; Fraser DG; Fath-Ordoubadi F
Eur Heart J; 2011 Apr; 32(8):972-82. PubMed ID: 21036776
[TBL] [Abstract][Full Text] [Related]
23. Effects of intravenous administration of tissue plasminogen activator before thrombectomy in patients with acute myocardial infarction.
Yamamoto S; Kamihata H; Sutani Y; Akita Y; Otani H; Iwasaka T
Circ J; 2006 Mar; 70(3):243-7. PubMed ID: 16501287
[TBL] [Abstract][Full Text] [Related]
24. Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction.
Gulba DC; Tanswell P; Dechend R; Sosada M; Weis A; Waigand J; Uhlich F; Hauck S; Jost S; Rafflenbeul W; Lichtlen PR; Dietz R
J Am Coll Cardiol; 1997 Dec; 30(7):1611-7. PubMed ID: 9385884
[TBL] [Abstract][Full Text] [Related]
25. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial.
Ross AM; Coyne KS; Reiner JS; Greenhouse SW; Fink C; Frey A; Moreyra E; Traboulsi M; Racine N; Riba AL; Thompson MA; Rohrbeck S; Lundergan CF
J Am Coll Cardiol; 1999 Dec; 34(7):1954-62. PubMed ID: 10588209
[TBL] [Abstract][Full Text] [Related]
26. Thrombolysis with a novel modified tissue-type plasminogen activator, monteplase, combined with catheter-based treatment for major pulmonary embolism.
Yamamoto T; Murai K; Tokita Y; Kato K; Iwasaki YK; Sato N; Tajima H; Mizuno K; Tanaka K
Circ J; 2009 Jan; 73(1):106-10. PubMed ID: 19043229
[TBL] [Abstract][Full Text] [Related]
27. [Long-term follow-up of patients with acute myocardial infarction treated with primary angioplasty or thrombolysis. Results of the MITRA trial].
Zhan R; Schiele R; Schneider S; Gitt AK; Heer T; Wienbergen H; Seidl K; Glunz HG; Hauptmann KE; Voigtländer T; Gottwik M; Senges J;
Z Kardiol; 2002 Jan; 91(1):49-57. PubMed ID: 11963207
[TBL] [Abstract][Full Text] [Related]
28. Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent intervention triage strategy), and HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trials.
Mehran R; Pocock S; Nikolsky E; Dangas GD; Clayton T; Claessen BE; Caixeta A; Feit F; Manoukian SV; White H; Bertrand M; Ohman EM; Parise H; Lansky AJ; Lincoff AM; Stone GW
JACC Cardiovasc Interv; 2011 Jun; 4(6):654-64. PubMed ID: 21700252
[TBL] [Abstract][Full Text] [Related]
29. Comparison of long-term prognostic evaluation between pre-intervention thrombolysis and primary coronary intervention: a prospective randomized trial: five-year results of the IMPORTANT study.
Itoh T; Fukami K; Suzuki T; Kimura T; Kanaya Y; Orii M; Goto I; Matsui H; Sugawara S; Nakajima S; Fusazaki T; Nakamura M;
Circ J; 2010 Aug; 74(8):1625-34. PubMed ID: 20571249
[TBL] [Abstract][Full Text] [Related]
30. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial.
Di Mario C; Dudek D; Piscione F; Mielecki W; Savonitto S; Murena E; Dimopoulos K; Manari A; Gaspardone A; Ochala A; Zmudka K; Bolognese L; Steg PG; Flather M;
Lancet; 2008 Feb; 371(9612):559-68. PubMed ID: 18280326
[TBL] [Abstract][Full Text] [Related]
31. Thrombolysis and percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction.
Zeymer U; Neuhaus KL
Z Kardiol; 2000; 89 Suppl 4():IV30-40. PubMed ID: 10810775
[TBL] [Abstract][Full Text] [Related]
32. Relation of corrected thrombolysis in myocardial infarction frame count and ST-segment resolution to myocardial tissue perfusion after acute myocardial infarction.
Li CM; Zhang XH; Ma XJ; Zhu XL
Catheter Cardiovasc Interv; 2008 Feb; 71(3):312-7. PubMed ID: 18288744
[TBL] [Abstract][Full Text] [Related]
33. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial.
Aversano T; Aversano LT; Passamani E; Knatterud GL; Terrin ML; Williams DO; Forman SA;
JAMA; 2002 Apr; 287(15):1943-51. PubMed ID: 11960536
[TBL] [Abstract][Full Text] [Related]
34. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
[TBL] [Abstract][Full Text] [Related]
35. Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Labinaz M; Sketch MH; Stebbins AL; DeFranco AC; Holmes DR; Kleiman NS; Betriu A; Rutsch WR; Vahanian A; Topol EJ; Califf RM
Am J Cardiol; 1996 Dec; 78(12):1338-44. PubMed ID: 8970403
[TBL] [Abstract][Full Text] [Related]
36. A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial.
Cannon CP; McCabe CH; Henry TD; Schweiger MJ; Gibson RS; Mueller HS; Becker RC; Kleiman NS; Haugland JM; Anderson JL
J Am Coll Cardiol; 1994 Apr; 23(5):993-1003. PubMed ID: 8144799
[TBL] [Abstract][Full Text] [Related]
37. [Effects of Tongxinluo Capsule on Platelet Activating Factor, Vascular Endothelial Function, Blood Flow of Thrombolysis in Myocardial Infarction in Acute Myocardial Infarction Patients after Delayed Percutaneous Coronary Intervention].
Chen ZQ; Hong L; Wang H; Yin QL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Apr; 36(4):415-20. PubMed ID: 27323611
[TBL] [Abstract][Full Text] [Related]
38. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2.
Widimský P; Budesínský T; Vorác D; Groch L; Zelízko M; Aschermann M; Branny M; St'ásek J; Formánek P;
Eur Heart J; 2003 Jan; 24(1):94-104. PubMed ID: 12559941
[TBL] [Abstract][Full Text] [Related]
39. Primary versus rescue percutaneous coronary intervention in patients with acute myocardial infarction.
Gimelli G; Kalra A; Sabatine MS; Jang IK
Acta Cardiol; 2000 Jun; 55(3):187-92. PubMed ID: 10902044
[TBL] [Abstract][Full Text] [Related]
40. Myocardial perfusion grade predicts final infarct size and left ventricular function in patients with ST-elevation myocardial infarction treated with a pharmaco-invasive strategy (thrombolysis and early angioplasty).
Bethke A; Halvorsen S; Bøhmer E; Abdelnoor M; Arnesen H; Hoffmann P
EuroIntervention; 2015 Sep; 11(5):518-24. PubMed ID: 25868877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
